Therapeutic Asset Ratings

342 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
BLOOD, WHOLE Glioblastoma	Centre Leon Berard	N/A	D (28)
BLOOD, WHOLE Hepatocellular Carcinoma	University Hospital, Angers	N/A	D (28)
BLOOD, WHOLE Lung Cancer	UNC Lineberger Comprehensive Cancer Center	N/A	D (28)
BLOOD, WHOLE Melanoma	Mayo Clinic		D (28)
BLOOD, WHOLE Non-Small Cell Lung Carcinoma	Paradigm Health		D (28)
BLOOD, WHOLE Small Cell Lung Carcinoma	University of Kansas Medical Center		D (28)
CLOSTRIDIUM BUTYRICUM MIYAIRI 588 Parkinson Disease	Kaohsiung Medical University Chung-Ho Memorial Hospital	N/A	D (28)
Enoxaparin Leukemia	Medical University of Gdansk	N/A	D (28)
LAC VACCINUM Obesity Disorder	USDA Grand Forks Human Nutrition Research Center	N/A	D (28)
BLOOD, WHOLE Breast Cancer	UNC Lineberger Comprehensive Cancer Center	N/A	D (26)
BLOOD, WHOLE Colorectal Cancer	UNC Lineberger Comprehensive Cancer Center	N/A	D (26)
BLOOD, WHOLE Obesity Disorder	University Hospital, Lille	N/A	D (26)
CLOSTRIDIUM BUTYRICUM MIYAIRI 588 Pancreatic Neoplasm	Casa di Cura Dott. Pederzoli	N/A	D (26)
Inulin Obesity Disorder	Midwest Center for Metabolic and Cardiovascular Research	N/A	D (26)
WHOLE WHEAT ALLERGENIC EXTRACT Obesity Disorder	University of Toronto	N/A	D (26)
HUMAN IMMUNE GLOBULIN G Chronic Inflammatory Demyelinating Polyradiculoneuropathy	Rutgers, The State University of New Jersey	P1	NR (0)
HUMAN IMMUNE GLOBULIN G Agammaglobulinemia	Rutgers, The State University of New Jersey	P1	NR (0)

Showing 326 to 342 of 342 assets

PreviousPage 14 of 14Next